Polio extraimmunization in children younger than 2 years after changes in immunization recommendations

Loren K Mell1, Robert L Davis, John P Mullooly

  • 1Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA.

Pediatrics
|February 4, 2003
PubMed

Insights

Poliovirus extraimmunization rates decreased significantly after the switch to the inactivated polio virus schedule. This change in polio immunization policy led to fewer children receiving extra doses by age two.

Area of Science:

  • Pediatric infectious diseases
  • Public health policy
  • Vaccine safety surveillance

Background:

  • Polio extraimmunization refers to receiving more polio vaccine doses than recommended.
  • Changes in polio immunization policy can impact vaccination practices.
  • Understanding trends in extraimmunization is crucial for vaccine program evaluation.

Purpose of the Study:

  • To analyze temporal trends in polio extraimmunization among children.
  • To examine the association between polio immunization schedules and extraimmunization.
  • To assess the impact of policy changes on polio vaccination practices.

Main Methods:

  • Retrospective cohort study using data from 176,169 children born after 1994.
  • Analysis of polio extraimmunization rates and trends using Vaccine Safety Datalink data.
  • Logistic and Poisson regression models to assess associations and changes over time.

Main Results:

  • Overall polio extraimmunization rate was 10.5%.
  • Children on inactivated or sequential polio virus schedules had lower extraimmunization rates compared to those on oral polio virus schedules.
  • A significant decrease in polio extraimmunization was observed from 1994 to 1997.

Conclusions:

  • Poliovirus extraimmunization rates have dramatically declined.
  • The shift to an all-inactivated polio virus schedule is associated with reduced extraimmunization.
  • Policy changes effectively influenced polio vaccination practices.
Abstract

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...